PERCIVIA

Serial Number 77310091
602

Registration Progress

Application Filed
Oct 22, 2007
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

PERCIVIA

Basic Information

Serial Number
77310091
Filing Date
October 22, 2007
Abandonment Date
September 4, 2009
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Oct 6, 2009
Classes
005 042 044

Rights Holder

Crucell Holland B.V.

03
Address
Archimedesweg 4
Leiden 2333
NL

Ownership History

Crucell Holland B.V.

Original Applicant
03
Leiden NL

Legal Representation

Attorney
Dana R. Kaplan, Esq.

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description Documents
Oct 6, 2009 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Oct 6, 2009 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Mar 3, 2009 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Mar 3, 2009 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Mar 3, 2009 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Feb 2, 2009 ALIE A ASSIGNED TO LIE Loading...
Feb 2, 2009 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Aug 1, 2008 CNSL R SUSPENSION LETTER WRITTEN Loading...
Aug 1, 2008 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Aug 1, 2008 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jul 18, 2008 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 18, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 18, 2008 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 7, 2008 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 7, 2008 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 7, 2008 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 31, 2008 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 25, 2007 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Live cells and cell-lines for medical or clinical use; media (culture broth) for the cultivation of cells and cell-lines; genetically modified materials for the preparation of pharmaceutical products and for research purposes; pharmaceutical products, namely diagnostic and therapeutic proteins
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Scientific and pharmaceutical research; services in the medical and biochemical field, namely expressing proteins; development, examination and testing of pharmaceutical and biochemical semi-finished products for use in medicines; the development of test systems for the products named in class 5; licensing in the field of intellectual property
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
Services in the medical and biomedical field; medical services
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042 044